The Food and Drug Administration in the US has just approved Cobenfy, which one researcher referred to as a "game changer" ...

A New York federal judge has dismissed a $6.4 billion lawsuit against Bristol Myers Squibb, agreeing with counsel for the ...

From Eli Lilly to Karuna Therapeutics to current owner Bristol Myers Squibb, the newly approved schizophrenia drug had quite ...

Warren Buffett is famous for being a value investor while Peter Lynch tended to be growth-oriented. Some investors are ...

Patients with a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, a new study found.

For the second time in 19 months, a federal judge in New York has dismissed a lawsuit claiming that Bristol Myers Squibb slow ...

District Judge Jesse Furman ruled that the plaintiff, UMB Bank, does not have standing to bring the case against Bristol ...

Patients with  a fast-spreading blood cancer respond well to outpatient treatment with CAR-T therapy, the largest ...

Bristol City Council, which owns the Bottle Yard Studios in Hengrove, is looking at options including selling the site. The Bottle Yard has hosted filming for productions like Sherlock ...

Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.

Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating on September 26. David Risinger ...

One of the drugs Royalty Pharma owns a stake in is Cobenfy, the new schizophrenia treatment from Bristol Myers Squibb. At its ...